Purchases and Sales Made in Q1 2025 in Arrowhead Pharmaceuticals, Inc. (ARWR)
This table provides information about the institutional ownership of Arrowhead Pharmaceuticals, Inc. (ARWR) during Q1 2025. The information is specifically focused on institutions that hold shares of ARROWHEAD PHARMACEUTICALS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 15, 2025
Q1 2025
|
Balyasny Asset Management LLC
Chicago, IL |
SELL
|
- |
-273K- 73.25% |
$3.48M - $5.88M
|
99.7K
$1.88M
|
|
|
May 13, 2025
Q1 2025
|
Northern Trust Corp
Chicago, IL |
SELL
|
- |
-274K- 18.43% |
$3.49M - $5.89M
|
1.21M
$22.9M
|
|
|
May 15, 2025
Q1 2025
|
Woodline Partners LP
San Francisco, CA |
SELL
|
- |
-278K- 33.09% |
$3.54M - $5.99M
|
562K
$10.6M
|
|
|
May 09, 2025
Q1 2025
|
Center Book Partners LP
Greenwich, CT |
SELL
|
- |
-284K- 80.91% |
$3.61M - $6.11M
|
66.9K
$1.26M
|
|
|
May 15, 2025
Q1 2025
|
Schonfeld Strategic Advisors LLC
New York, NY |
SELL
|
- |
-580K- 91.68% |
$7.38M - $12.5M
|
52.6K
$993K
|
|
|
May 15, 2025
Q1 2025
|
Farallon Capital Management LLC
San Francisco, CA |
SELL
|
- |
-613K- 97.49% |
$7.81M - $13.2M
|
15.8K
$298K
|
|
|
May 14, 2025
Q1 2025
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-616K- 93.92% |
$7.85M - $13.3M
|
39.9K
$753K
|
|
|
May 12, 2025
Q1 2025
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-1.53M- 75.86% |
$19.5M - $33M
|
488K
$9.21M
|